Precision BioSciences Inc (DTIL)
Drugs • Health Care
Percentage
Change
| Mar 20 | Mar 21 | Mar 22 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | |
|---|---|---|---|---|---|---|---|
Net Income to Common | 7 | -46 | |||||
Net Income | 7 | -46 | |||||
Profit | 7 | -46 | |||||
Net Income Discontinued | 0 | 1 | |||||
Net Income Continuing | 7 | -47 | |||||
Pretax Income | 7 | -47 | |||||
Total Non-operating Income | 33 | 6 | |||||
Operating Income | -26 | -52 | |||||
Total Revenue | 69 | 34 | |||||
Total Costs and Expenses | -95 | -86 | |||||
Operating Expenses | -95 | -86 | |||||
Impairment Expense | 0 | -0 | |||||
Research and Development Expenses | -60 | -54 | |||||
Selling, General & Administrative Expenses | -35 | -32 | |||||
Other Operating Expenses | 0 | 0 |